Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin

Author： Kanda Tatsuo   Nakamura Masato   Yasui Shin   Haga Yuki   Tawada Akinobu   Suzuki Eiichiro   Ooka Yoshihiko   Takahashi Koji   Sasaki Reina   Wu Shuang   Nakamoto Shingo   Arai Makoto   Imazeki Fumio   Yokosuka Osamu  

Publisher： MDPI

E-ISSN： 2079-7737|6|2|30-30

ISSN： 2079-7737

Source： Biology, Vol.6, Iss.2, 2017-05, pp. : 30-30

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors

By Kanda Tatsuo   Yasui Shin   Nakamura Masato   Suzuki Eiichiro   Arai Makoto   Ooka Yoshihiko   Ogasawara Sadahisa   Chiba Tetsuhiro   Saito Tomoko   Haga Yuki   Takahashi Koji   Sasaki Reina   Wu Shuang   Nakamoto Shingo   Tawada Akinobu   Maruyama Hitoshi   Imazeki Fumio   Kato Naoya   Yokosuka Osamu  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-04 ,pp. : 906-906

MDPI

Access to resources Recommend Favorite

Interleukin‐28b CC genotype predicts early treatment response and CT/TT genotypes predicts non‐response in patients infected with HCV genotype 3

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 86, Iss. 4, 2014-04 ,pp. : 707-712

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized trial of peginterferon alpha‐2b plus low and escalating dose of ribavirin in patients with chronic hepatitis C with high viral load genotype 1

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 4, 2015-04 ,pp. : 625-633

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized trial of low‐dose peginterferon α‐2b plus low and escalating doses of ribavirin in older patients with chronic hepatitis C with high viral load genotype 1

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 146-6615, Iss. 12, 2015-12 ,pp. : 2082-2089

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype‐4 chronic hepatitis C patients

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 88, Iss. 12, 2016-12 ,pp. : 2170-2178

John Wiley & Sons Inc

Access to resources Recommend Favorite